“Everyone with nasal polyps should try treatment with medicines, before considering surgery (unless there is any doubt about whether there is a more serious problem, such as tumour). Medicines for nasal polyps might be topical (for example, drops and sprays), or tablets.”
– Kenny and Knott, Patient. Nasal Polyps. 2014
Typically, something that takes one’s breath away is amazing. Nasal polyps, however, can literally take away people’s breath by making it difficult to breathe. Nasal polyps are a common problem, but current treatment options are lacking.
Nasal polyps affect up to 4% of people, according to a 2008 article in Therapeutics and Clinical Risk Management. Although the cause of nasal polyps is unknown, certain characteristics are established risk factors. People who have asthma, allergies and cystic fibrosis are most likely to develop nasal polyps. The polyps can reduce quality of life through nasal congestion or obstruction, frequent infection and loss of smell or taste. Difficulty breathing is one of the most dangerous side effects.
Current medications used to treat these symptoms are less than optimal. Such treatments include antihistamines and nasal, oral and injectable steroids. According to a 2012 Healthline article, steroids can’t be used in the long term because of the serious adverse events, such as eye pressure and raised blood pressure. Additionally, steroids require frequent dosing. Surgery to remove the polyps is an option if medications do not alleviate symptoms. Unfortunately, nasal polyps often return after surgery.
Despite the prevalence of nasal polyps, current treatment options are lacking. That’s why Orbis BiosciencesTM is applying Precision Particle FabricationTM technology to the problem. The Orbis solution is a long-acting steroid with dose-format flexibility that requires fewer doses than conventional steroids. With this long-acting medication, the most breathtaking part about nasal polyps will be the efficiency of their treatment.